Clinical phenotyping: role in treatment decisions in sarcoidosis

Robert P. Baughman, Mary Beth Scholand, Franck F. Rahaghi

Source: Eur Respir Rev, 29 (155) 190145; 10.1183/16000617.0145-2019
Journal Issue: March
Disease area: -

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Robert P. Baughman, Mary Beth Scholand, Franck F. Rahaghi. Clinical phenotyping: role in treatment decisions in sarcoidosis. Eur Respir Rev, 29 (155) 190145; 10.1183/16000617.0145-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
The cryoTBB role in the diagnostic work-up of IPF: an European perspective; emergent standardization guidelines
Source: ERS Online Course 2019: Biopsy techniques and pathology of ILD
Year: 2019

Management of sarcoidosis in clinical practice
Source: Eur Respir Rev 2016; 25: 141-150
Year: 2016

The role of clinical history and investigations in the diagnosis and exclusion of tuberculosis
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013

Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers
Source: Eur Respir J, 55 (5) 2001028; 10.1183/13993003.01028-2020
Year: 2020

The role of various methods in the diagnosis of tuberculous pleurisy in clinical practice
Source: Eur Respir J 2002; 20: Suppl. 38, 580s
Year: 2002

Severe sarcoidosis: clinical features and management
Source: Virtual Congress 2021 – Rare lung diseases 2021
Year: 2021

Potential protective role of prior to diagnosis antibiotic treatment in community-acquired pneumonia: Clinical presentation and outcomes
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011

Clinical pneumonia: how do I make a specific diagnosis?
Source: Virtual Congress 2021 – The "State of the Art" in the diagnosis of bacterial, mycobacterial, and fungal pneumonias
Year: 2021

Cxr interpretation in patients presenting with an acute infective exacerbation of COPD: comparison between clinicians‘ and radiologists‘ interpretations and implications on clinical decision and management
Source: Annual Congress 2009 - Imaging of COPD, asthma and emphysema in evolution
Year: 2009

Guidelines versus clinical practice in the treatment of COPD: a reappraisal
Source: Eur Respir J 2006; 27: 656
Year: 2006

Clinical, functional and laboratory assessment of treatment efficacy in COPD patients
Source: International Congress 2014 – Predictors
Year: 2014

Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice
Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies
Year: 2009

Transcriptional biomarkers for predicting development of tuberculosis: progress and clinical considerations
Source: Eur Respir J, 55 (3) 1901957; 10.1183/13993003.01957-2019
Year: 2020

Clinical approach to the diagnosis and assessment of AATD
Source: Eur Respir Monogr 2019; 85: 64-77
Year: 2019

Initial diagnosis and management of COPD - the role of primary care and when to refer
Source: Annual Congress 2003 - PG12 - COPD - diagnosis, pathogenesis and the role of primary relative to secondary care in management
Year: 2003

Importance of clinical, radiological and functional methods of investigation for diagnosis and assessment of the efficiency of treatment of Langerhans' cell histiocytosis
Source: Eur Respir J 2001; 18: Suppl. 33, 383s
Year: 2001

A critical evaluation of the relevance of different asthma phenotypes for clinical practice
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008